Target intelligence / Profile preview

Intracellular proteins with metal-chelating residues

Molecular classification
Other, Metalloprotein
01

Overview

Intracellular proteins with metal-chelating residues refers to a broad class of proteins that possess amino acid side chains, such as histidine, cysteine, aspartate, or glutamate, capable of coordinating metal ions like iron, copper, or zinc (UniProt, 2024). These proteins play critical roles in cellular processes including enzymatic catalysis, structural stability, and metal ion homeostasis (PubMed, 2023). In a pharmacological context, this term is often used to describe the collective target of intracellular chelating agents like dexrazoxane (DrugBank, DB00380). By binding to the metal ions associated with these proteins, such drugs prevent the formation of toxic metal-drug complexes, such as iron-anthracycline complexes, and the subsequent generation of reactive oxygen species (StatPearls, NBK559245). This mechanism is primarily utilized to mitigate oxidative stress-induced damage, such as the cardiotoxicity associated with certain chemotherapeutic agents (NIH, 2023). Consequently, while not a single molecular entity, these proteins represent a significant site for therapeutic intervention in managing metal-mediated toxicity and oxidative injury.

Other names
Intracellular metalloproteinsMetal-binding proteinsIntracellular metal-coordinating proteins
02

Mechanism of action

Chelation of intracellular metal ions (primarily iron) to prevent the formation of metal-anthracycline complexes and subsequent reactive oxygen species (ROS) generation.

03

Biological functions

Metal ion homeostasisRedox regulationOxidative stress modulation
04

Disease associations

Cardiovascular diseaseCancer
05

Safety considerations

MyelosuppressionSecondary malignanciesInterference with chemotherapy efficacy
06

Interacting drugs

Dexrazoxane
07

Biomarkers

Troponin ITroponin TBrain natriuretic peptide (BNP)Left ventricular ejection fraction (LVEF)

Beyond the preview

Go deeper on Intracellular proteins with metal-chelating residues.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intracellular proteins with metal-chelating residues.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call